U.S. Pharmaceutical Industry Seen to Focus on COVID-19 Treatments Amid Competitive Environment
ArchIntel
JUNE 2, 2021
This fierce competition is predicted to propel the U.S. As each company makes a dash to develop a better cure, their competitive intelligence professionals are seen to be just as busy divining insights that will put clarity in an uncertain market. These are some of the U.S. She worked for the firm for two and a half years.
104 
Let's personalize your content